SCHEMBL7708571

SCHEMBL7708571

COc1cccc(-c2nc3cc(Br)cc(N)n3n2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HPGD P15428 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
TGFBR1 P36897 10/20 0.38
ADORA2A P29274 2/20 0.37
NFKB1 P19838 1/20 0.36
HTT P42858 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
CYP11B2 P19099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7709147 0.83 KDR (0.48) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1
SCHEMBL7438035 0.76 ADORA2A (0.59) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1
SCHEMBL7430006 0.76 ADORA2A (0.49) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1
SCHEMBL7434291 0.73 ALDH1A1 (0.57) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1
SCHEMBL7711665 0.72 ALDH1A1 (0.39) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1
SCHEMBL7431271 0.70 AMY1A (0.50) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1
SCHEMBL7703259 0.70 ALDH1A1 (0.42) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1
SCHEMBL7433615 0.70 KDM4E (0.39) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1
SCHEMBL7428728 0.69 ALDH1A1 (0.43) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1
SCHEMBL7480280 0.69 ADORA2A (0.59) ALDH1A1KDM4ESMN1; SMN2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed